MarketsNotableSingle-sourceDeveloping
4.9
Trump announces nine new drug pricing deals with manufacturers
STAT NewsLO·US·1 day ago
HealthSingle-sourceMediumDeveloping
4.8
Trump drug pricing deals raise implementation questions
The Trump administration has reached pricing agreements with drugmakers, but key details on scope, enforcement, and impact remain unclear. The deals could reshape pharmaceutical pricing dynamics, though their durability and effect on innovation are uncertain.
Score Breakdown
Mosaic Score4.8
Confidence0.5
Significance0.5
Source credibility0.2
Intelligence Tags
Locations
Washington, D.C.
Entities
countryperson
Related signals
8 foundTradeNotableConfirmedDeveloping
5.8
Dutch pharmaceutical firm Tiofarma loses major contract citing US tariff threats
FDLO·NL · US·3 days ago
GeopoliticsNotableSingle-sourceDeveloping
5.6
California Sues Trump Admin Over $120M Offshore Wind Buyout Cancellation
gCaptain·US·1 day ago
HealthNotableSingle-sourceDeveloping
5.4
Poland Ministry of Health threatens to delist 1,500 drugs from 65+ free medication program over pricing
Gazeta Wyborcza·PL·2 days ago
PoliticsNotableSingle-sourceDeveloping
5.3
Pediatrician Annie Andrews to face Graham's sister in SC Senate race
Guardian WorldLO·US·1 day ago
HealthNotableSingle-sourceDeveloping
5.3
Greek Pharmaceutical Association warns of unsustainable clawback mechanisms
Capital.grLO·GR·2 days ago
HealthNotableSingle-sourceDeveloping
5.3
Novo Nordisk and Eli Lilly initiate legal action against counterfeit GLP-1 drug manufacturers
FDLO·DK · US·3 days ago
JusticeNotableSingle-sourceDeveloping
5.2
Orexo reaches non-binding settlement agreement with U.S. Department of Justice
Dagens IndustriLO·SE · US·2 days ago